Entecavir treatment in HBV-related decompensated cirrhosis

Author： Alexopoulou Alexandra   Papatheodoridis George V  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.6, Iss.11, 2011-11, pp. : 1275-1281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Entecavir for the treatment of patients with hepatitis B virus-related decompensated cirrhosis

By Sadler Matthew D   Coffin Carla S   Lee Samuel S  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1363-1369

Informa Healthcare

Access to resources Recommend Favorite

Entecavir: A Review of its Use in the Treatment of Chronic Hepatitis B in Patients with Decompensated Liver Disease

By Keating Gillian M.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2511-2529

Adis International

Access to resources Recommend Favorite

Lamivudine: Development of resistance leading to HBV-related membranous nephropathy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1434, 2013-01 ,pp. : 40-40

Adis International

Access to resources Recommend Favorite

HBV-related hepatocellular carcinoma: the role of integration, viral proteins and miRNA

By Lim Lucy   Tran Bang Manh   Vincan Elizabeth   Locarnini Stephen   Warner Nadia  

Future Virology, Vol. 7, Iss. 12, 2012-12 ,pp. : 1237-1249

Future Medicine

Access to resources Recommend Favorite

Entecavir "economically attractive" in US for chronic HBV

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 549, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite